Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Global Acne Medication Market 2022
Acne is a skin condition that occurs when your hair follicles become plugged with oil and dead skin cells. It causes whiteheads, blackheads or pimples. Acne is most common among teenagers, though it affects people of all ages. A study by StrategyHelix indicates that the global acne medication market is expected to increase by US$ 2,037.0 million from 2022 to 2028, garnering a CAGR of 5.2% during the forecast period.
The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for acne medication. The global acne medication market is segmented on the basis of therapeutic class, route of administration, type, and region. Based on therapeutic class, the global acne medication market is categorized into retinoids, antibiotics, hormonal agents, others. The retinoids segment captured the largest share of the market in 2021. On the basis of route of administration, the global acne medication market has been segmented into topical, oral. The topical segment held the largest share of the global acne medication market in 2021 and is anticipated to hold its share during the forecast period. By type, the global acne medication market has been segmented into prescription medicine, over-the-counter (OTC) medicine. In 2021, the over-the-counter (OTC) medicine segment made up the largest share of revenue generated by the acne medication market. In terms of geography, the global acne medication market has been segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).
The global acne medication market is highly competitive. As of 2021, the major players in the global acne medication market were Allergan plc, Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestle S.A.), GlaxoSmithKline Plc (GSK), Mylan N.V., Perrigo Company plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the acne medication market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Therapeutic class: retinoids, antibiotics, hormonal agents, others
Route of administration: topical, oral
Type: prescription medicine, over-the-counter (OTC) medicine
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028
Key Benefits for Stakeholders
– Get a comprehensive picture of the global acne medication market
– Pinpoint growth sectors and trends for investment
Table of Contents
Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Acne medication market overview
Part 3. Market breakdown by therapeutic class
– Hormonal agents
Part 4. Market breakdown by route of administration
Part 5. Market breakdown by type
– Prescription medicine
– Over-the-counter (OTC) medicine
Part 6. Market breakdown by region
– North America
– Asia Pacific
– Rest of the World (ROW)
Part 7. Key companies
– Allergan plc
– Bausch Health Companies Inc.
– F. Hoffmann-la Roche Ltd.
– Galderma S.A. (Nestle S.A.)
– GlaxoSmithKline Plc (GSK)
– Mylan N.V.
– Perrigo Company plc
– Pfizer Inc.
– Teva Pharmaceutical Industries Ltd.